Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Reinhardt

Showing results (41-50 of 223) with videos related to

Pageof 23
Sort By:
Medical and Pediatric Oncology|March 26, 2003
Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemiaClaudia Lanvers, Dirk Reinhardt, Angelika Dübbers, et al.
Cell & Bioscience|March 29, 2022
DNA in extracellular vesicles: from evolution to its current application in health and diseaseJamal Ghanam, Venkatesh Kumar Chetty, Lennart Barthel, et al.
Cytometry. Part B, Clinical Cytometry|December 30, 2004
Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoringClaudia Langebrake, Iris Brinkmann, Andrea Teigler-Schlegel, et al.
Annals of Hematology|January 24, 2019
Detection of AML-specific mutations in pediatric patient plasma using extracellular vesicle-derived RNAFabienne Kunz, Evangelia Kontopoulou, Katarina Reinhardt, et al.
BMC Bioinformatics|September 25, 2015
Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisitedAskar Obulkasim, Maarten Fornerod, Michel C Zwaan, et al.
Pediatric Blood & Cancer|January 28, 2016
Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004Angela Hassler, Konrad Bochennek, Julia Gilfert, et al.
European Journal of Medical Genetics|June 12, 2021
A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemiaIvana Radulovic, Alma Kuechler, Michael M Schündeln, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group, Claudia Langebrake, Ursula Creutzig, et al.
Cancer|December 14, 2007
Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98AUrsula Creutzig, Thomas Büchner, Maria C Sauerland, et al.
Pediatric Blood & Cancer|July 5, 2024
Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndromeMilica Miladinovic, Dirk Reinhardt, Henrik Hasle, et al.
Pageof 23

Showing results (41-50 of 223) with videos related to

Sort By:
Pageof 23
Medical and Pediatric Oncology|March 26, 2003
Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemiaClaudia Lanvers, Dirk Reinhardt, Angelika Dübbers, et al.
Cell & Bioscience|March 29, 2022
DNA in extracellular vesicles: from evolution to its current application in health and diseaseJamal Ghanam, Venkatesh Kumar Chetty, Lennart Barthel, et al.
Cytometry. Part B, Clinical Cytometry|December 30, 2004
Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoringClaudia Langebrake, Iris Brinkmann, Andrea Teigler-Schlegel, et al.
Annals of Hematology|January 24, 2019
Detection of AML-specific mutations in pediatric patient plasma using extracellular vesicle-derived RNAFabienne Kunz, Evangelia Kontopoulou, Katarina Reinhardt, et al.
BMC Bioinformatics|September 25, 2015
Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisitedAskar Obulkasim, Maarten Fornerod, Michel C Zwaan, et al.
Pediatric Blood & Cancer|January 28, 2016
Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004Angela Hassler, Konrad Bochennek, Julia Gilfert, et al.
European Journal of Medical Genetics|June 12, 2021
A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemiaIvana Radulovic, Alma Kuechler, Michael M Schündeln, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group, Claudia Langebrake, Ursula Creutzig, et al.
Cancer|December 14, 2007
Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98AUrsula Creutzig, Thomas Büchner, Maria C Sauerland, et al.
Pediatric Blood & Cancer|July 5, 2024
Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndromeMilica Miladinovic, Dirk Reinhardt, Henrik Hasle, et al.
Pageof 23